secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0000310764-21-000144
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q3: adj EPS $2.20 (+2.8%); organic sales +4.5%; China impairment $105M; guidance revised
--------------------------------------------------------------------------------

- Net sales $4.2B, +11.3% vs 2020; organic net sales +4.5% vs 2020 and +8.4% vs 2019.
- Reported EPS $1.14 (down 30.1%); adjusted EPS $2.20 (up 2.8%) due to $105M impairment.
- $105M impairment for China trauma/joint replacement VBP price reductions impacting Orthopaedics.
- 2021 outlook: organic sales growth 7%-8% from 2019; adj EPS $9.08-$9.15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076421000144/0000310764-21-000144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076421000144/syk-20211028.htm
  HTML page:      https://secwatch.observer/filing/0000310764-21-000144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer